Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION StudyMyung‐Ju Ahn, Maen Hussein, Ewa Kalinka‐Warzocha et al.|Journal of Thoracic Oncology|2023Cited by 11